161 related articles for article (PubMed ID: 35938142)
1. Genomic and Immunological Characterization of Pyroptosis in Lung Adenocarcinoma.
Song Y; Qu Z; Feng H; Xu L; Xiao Y; Zhao Z; Wu D; Sun C; Fan X; Zhou D
J Oncol; 2022; 2022():6905588. PubMed ID: 35938142
[TBL] [Abstract][Full Text] [Related]
2. Novel molecular insights into pyroptosis in triple-negative breast cancer prognosis and immunotherapy.
Yu B; Luo J; Yang Y; Zhen K; Shen B
J Gene Med; 2024 Jan; 26(1):e3645. PubMed ID: 38041540
[TBL] [Abstract][Full Text] [Related]
3. Identification of Pyroptosis-Relevant Signature in Tumor Immune Microenvironment and Prognosis in Skin Cutaneous Melanoma Using Network Analysis.
Zhu Y; Han D; Duan H; Rao Q; Qian Y; Chen Q; Du X; Ni H; Wang S
Stem Cells Int; 2023; 2023():3827999. PubMed ID: 36818162
[TBL] [Abstract][Full Text] [Related]
4. A Pyroptosis-Related Signature Predicts Overall Survival and Immunotherapy Responses in Lung Adenocarcinoma.
Zhu K; Yan A; Zhou F; Zhao S; Ning J; Yao L; Shang D; Chen L
Front Genet; 2022; 13():891301. PubMed ID: 35795208
[No Abstract] [Full Text] [Related]
5. A novel pyroptosis related genes signature for predicting prognosis and estimating tumor immune microenvironment in lung adenocarcinoma.
Wu C; Zhao J; Wang X; Wang Y; Zhang W; Zhu G
Transl Cancer Res; 2022 Aug; 11(8):2647-2659. PubMed ID: 36093538
[TBL] [Abstract][Full Text] [Related]
6. Pyroptosis-based risk score predicts prognosis and drug sensitivity in lung adenocarcinoma.
Jiang Z; Wang X; Huang J; Li G; Li S
Open Med (Wars); 2023; 18(1):20230663. PubMed ID: 36941988
[TBL] [Abstract][Full Text] [Related]
7. Risk factors analysis and survival prediction model establishment of patients with lung adenocarcinoma based on different pyroptosis-related gene subtypes.
Wen Z; Pei B; Dai L; Lu P; Li X; Zhang C; Ge S
Eur J Med Res; 2023 Dec; 28(1):601. PubMed ID: 38111060
[TBL] [Abstract][Full Text] [Related]
8. A New Risk Score Model Based on Pyrogenic Signatures for the Prediction of Survival and Immune Microenvironment Features in Lung Adenocarcinoma.
Zhao L; Wang L; Guo T; Gu C; Wang J
Int J Gen Med; 2023; 16():2323-2336. PubMed ID: 37313044
[TBL] [Abstract][Full Text] [Related]
9. A pyroptosis-related gene model and its correlation with the microenvironment of lung adenocarcinoma: A bioinformatics analysis and experimental verification.
Dong Y; Yi L; Song Q; Yao Y
Front Genet; 2022; 13():997319. PubMed ID: 36437954
[No Abstract] [Full Text] [Related]
10. Immune- and Stemness-Related Genes Revealed by Comprehensive Analysis and Validation for Cancer Immunity and Prognosis and Its Nomogram in Lung Adenocarcinoma.
Chen M; Wang X; Wang W; Gui X; Li Z
Front Immunol; 2022; 13():829057. PubMed ID: 35833114
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Signature and Discrimination Signature of Lung Adenocarcinoma based on Pyroptosis-Related Genes.
Li GS; Lu HP; Gao L; Li JD; He RQ; Zhou HF; Chen SW; Liu J; Fu ZW; Kong JL; Zeng JH; He J; Chen G
Comb Chem High Throughput Screen; 2023; 26(2):347-361. PubMed ID: 35593363
[TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma.
Liu J; Liu Q; Shen H; Liu Y; Wang Y; Wang G; Du J
Front Genet; 2022; 13():838624. PubMed ID: 35928454
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis-Related Signature Predicts Prognosis and Immune Microenvironment Infiltration in Lung Adenocarcinoma.
Zou X; He R; Zhang Z; Yan Y
Front Genet; 2022; 13():818403. PubMed ID: 35571020
[TBL] [Abstract][Full Text] [Related]
14. Identification of a Pyroptosis-Related Gene Signature for Prediction of Overall Survival in Lung Adenocarcinoma.
Dong Z; Bian L; Wang M; Wang L; Wang Y
J Oncol; 2021; 2021():6365459. PubMed ID: 34630565
[TBL] [Abstract][Full Text] [Related]
15. Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis.
Huang H; Shi Z; Li Y; Zhu G; Chen C; Zhang Z; Shi R; Su L; Cao P; Pan Z; Zhang H; Liu M; Liu H; Chen J
Front Oncol; 2022; 12():850943. PubMed ID: 35311148
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Four-Gene Signature Associated with the Prognosis Prediction of Lung Adenocarcinoma Based on Integrated Bioinformatics Analysis.
Wu Y; Yang L; Zhang L; Zheng X; Xu H; Wang K; Weng X
Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205284
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Pyroptosis-Related Gene Signature for Predicting the Immune Status and Prognosis in Lung Adenocarcinoma.
Gong Z; Li Q; Yang J; Zhang P; Sun W; Ren Q; Tang J; Wang W; Gong H; Li J
Front Bioeng Biotechnol; 2022; 10():852734. PubMed ID: 35646872
[No Abstract] [Full Text] [Related]
18. A New Hypoxia-Related Prognostic Risk Score (HPRS) Model Was Developed to Indicate Prognosis and Response to Immunotherapy for Lung Adenocarcinoma.
Yang X; Liang M; Yu Z; Fan J
J Oncol; 2022; 2022():6373226. PubMed ID: 35942407
[TBL] [Abstract][Full Text] [Related]
19. A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma.
Li F; Ge D; Sun SL
BMC Pulm Med; 2021 Jul; 21(1):229. PubMed ID: 34256754
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Lung Adenocarcinoma.
Huang H; Zhu G; Shi R; Li Y; Zhang Z; Xu S; Chen C; Cao P; Pan Z; Zhang H; Liu M; Liu H; Chen J
J Cancer; 2022; 13(8):2631-2643. PubMed ID: 35711827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
